Search Results

There are 15770 results for: content related to: Regulatory macrophages induced by infliximab are involved in healing in vivo and in vitro

  1. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Version of Record online : 11 OCT 2012, DOI: 10.1002/art.37735

  2. Trough levels and antibodies to infliximab may not predict response to intensification of infliximab therapy in patients with inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 7, July 2012, Pages: 1199–1206, Benjamin Pariente, Guillaume Pineton de Chambrun, Roman Krzysiek, Marine Desroches, Gauthier Louis, Chiara De Cassan, Clotilde Baudry, Jean-Marc Gornet, Pierre Desreumaux, Dominique Emilie, Jean-Frédéric Colombel and Matthieu Allez

    Version of Record online : 29 AUG 2011, DOI: 10.1002/ibd.21839

  3. You have free access to this content
    Review article: pharmacological aspects of anti-TNF biosimilars in inflammatory bowel diseases

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 10, November 2015, Pages: 1158–1169, K. Papamichael, T. Van Stappen, V. Jairath, K. Gecse, R. Khanna, G. D'Haens, S. Vermeire, A. Gils, B. G. Feagan, B. G. Levesque and N. Vande Casteele

    Version of Record online : 13 SEP 2015, DOI: 10.1111/apt.13402

  4. Pharmacokinetics of anti-TNF monoclonal antibodies in inflammatory bowel disease: Adding value to current practice

    The Journal of Clinical Pharmacology

    Volume 55, Issue S3, March 2015, Pages: S39–S50, Niels Vande Casteele and Ann Gils

    Version of Record online : 23 FEB 2015, DOI: 10.1002/jcph.374

  5. The outcome of infliximab dose doubling in 157 patients with ulcerative colitis after loss of response to infliximab

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 10, November 2015, Pages: 1192–1199, G. Dumitrescu, A. Amiot, P. Seksik, C. Baudry, C. Stefanescu, C. Gagniere, M. Allez, J. Cosnes and Y. Bouhnik

    Version of Record online : 10 SEP 2015, DOI: 10.1111/apt.13393

  6. You have free access to this content
    Antitumor necrosis factor treatment for pediatric inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 5, May 2012, Pages: 985–1002, Charlotte I. de Bie, Johanna C. Escher and Lissy de Ridder

    Version of Record online : 20 SEP 2011, DOI: 10.1002/ibd.21871

  7. Comparative cost-effectiveness of strategies to prevent postoperative clinical recurrence of Crohn's disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 9, September 2012, Pages: 1608–1616, Glen A. Doherty, Rebecca A. Miksad, Adam S. Cheifetz and Alan C. Moss

    Version of Record online : 8 SEP 2011, DOI: 10.1002/ibd.21904

  8. Clinical utility of antihuman lambda chain-based enzyme-linked immunosorbent assay (ELISA) versus double antigen ELISA for the detection of anti-infliximab antibodies

    Inflammatory Bowel Diseases

    Volume 18, Issue 9, September 2012, Pages: 1628–1633, Uri Kopylov, Yoav Mazor, Miri Yavzori, Ella Fudim, Lior Katz, Daniel Coscas, Orit Picard, Yehuda Chowers, Rami Eliakim and Shomron Ben-Horin

    Version of Record online : 29 OCT 2011, DOI: 10.1002/ibd.21919

  9. Direct medical cost of managing IBD patients: A Canadian population-based study

    Inflammatory Bowel Diseases

    Volume 18, Issue 8, August 2012, Pages: 1498–1508, Charles N. Bernstein, Teresa Longobardi, Greg Finlayson and James F. Blanchard

    Version of Record online : 22 NOV 2011, DOI: 10.1002/ibd.21878

  10. You have free access to this content
    Light on the Horizont: biologicals in Behçet uveitis

    Acta Ophthalmologica

    Volume 91, Issue 4, June 2013, Pages: 297–306, Dicle Hazirolan, Nicole Stübiger and Uwe Pleyer

    Version of Record online : 20 APR 2012, DOI: 10.1111/j.1755-3768.2011.02348.x

  11. Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti-TNF therapy

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 4, August 2015, Pages: 391–405, J. P. Gisbert, A. C. Marín and M. Chaparro

    Version of Record online : 15 JUN 2015, DOI: 10.1111/apt.13276

  12. Biologics in oral medicine: oral Crohn’s disease and orofacial granulomatosis

    Oral Diseases

    Volume 18, Issue 7, October 2012, Pages: 633–638, ID O’Neill and C Scully

    Version of Record online : 15 MAR 2012, DOI: 10.1111/j.1601-0825.2012.01918.x

  13. Clinical impact of concomitant immunomodulators on biologic therapy: Pharmacokinetics, immunogenicity, efficacy and safety

    The Journal of Clinical Pharmacology

    Volume 55, Issue S3, March 2015, Pages: S60–S74, Zhenhua Xu, Hugh M. Davis and Honghui Zhou

    Version of Record online : 23 FEB 2015, DOI: 10.1002/jcph.380

  14. You have free access to this content
    Postoperative recurrent luminal Crohn's Disease: A systematic review

    Inflammatory Bowel Diseases

    Volume 18, Issue 4, April 2012, Pages: 758–777, Peter De Cruz, Michael A. Kamm, Lani Prideaux, Patrick B. Allen and Paul V. Desmond

    Version of Record online : 9 AUG 2011, DOI: 10.1002/ibd.21825

  15. Infliximab for steroid refractory or dependent gastrointestinal acute graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation

    Pediatric Transplantation

    Volume 16, Issue 7, November 2012, Pages: 771–778, Jun Yang, Daniel Ka Leung Cheuk, Shau Yin Ha, Alan Kwok Shing Chiang, Tsz Leung Lee, Marco Hok Kung Ho and Godfrey Chi Fung Chan

    Version of Record online : 20 AUG 2012, DOI: 10.1111/j.1399-3046.2012.01756.x

  16. Genes associated with intestinal permeability in ulcerative colitis: Changes in expression following infliximab therapy

    Inflammatory Bowel Diseases

    Volume 18, Issue 8, August 2012, Pages: 1399–1410, Gary Toedter, Katherine Li, Sarah Sague, Keying Ma, Colleen Marano, Michael Macoritto, Jennifer Park, Renée Deehan, Andrea Matthews, Gary D. Wu, James D. Lewis, Ingrid Arijs, Paul Rutgeerts and Frédéric Baribaud

    Version of Record online : 4 JAN 2012, DOI: 10.1002/ibd.22853

  17. Infliximab does not affect postoperative complication rates in Crohn's patients undergoing abdominal surgery

    Inflammatory Bowel Diseases

    Volume 18, Issue 7, July 2012, Pages: 1207–1213, Michael S. Kasparek, Andreas Bruckmeier, Florian Beigel, Mario H. Müller, Stephan Brand, Ulrich Mansmann, Karl-Walter Jauch, Thomas Ochsenkühn and Martin E. Kreis

    Version of Record online : 16 SEP 2011, DOI: 10.1002/ibd.21860

  18. Retrieval of serum infliximab level by shortening the maintenance infusion interval is correlated with clinical efficacy in Crohn's disease

    Inflammatory Bowel Diseases

    Volume 18, Issue 8, August 2012, Pages: 1480–1487, Toshifumi Hibi, Atsushi Sakuraba, Mamoru Watanabe, Satoshi Motoya, Hiroaki Ito, Kenta Motegi, Yoshitaka Kinouchi, Masakazu Takazoe, Yasuo Suzuki, Takayuki Matsumoto, Kazuhiko Kawakami, Takayuki Matsumoto, Ichiro Hirata, Shinji Tanaka, Toshifumi Ashida and Toshiyuki Matsui

    Version of Record online : 10 OCT 2011, DOI: 10.1002/ibd.21886

  19. Mucosal healing in Crohn's disease: A systematic review

    Inflammatory Bowel Diseases

    Peter De Cruz, Michael A. Kamm, Lani Prideaux, Patrick B. Allen and Greg Moore

    Version of Record online : 26 APR 2012, DOI: 10.1002/ibd.22977

  20. You have free access to this content
    Systematic review with meta-analysis: infliximab and immunosuppressant therapy vs. infliximab alone for active ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 41, Issue 7, April 2015, Pages: 603–612, D. Christophorou, N. Funakoshi, Y. Duny, J.-C. Valats, M. Bismuth, G. Pineton De Chambrun, J.-P. Daures and P. Blanc

    Version of Record online : 10 FEB 2015, DOI: 10.1111/apt.13102